FUSIONSPOLYPEPTID GEGEN KREBS

Patent europeic · EP3298030 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3298030
Numer da la dumonda
EP16729794
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
18-05-2016
Publitgà
28-03-2018
Concedì
18-01-2023
La protecziun finescha il pli tard
17-05-2036
Proxima taxa annuala scadenta
31-05-2026
Classas IPC
C07K 14/47 (2006.01)
C07K 16/28 (2006.01)
C07K 14/705 (2006.01)
Prioritad
EP 15167927 18.05.2015
EP 16150508 08.01.2016
Dumonda PCT
PCT/EP2016/061071 18.05.2016
Publicaziun PCT
WO2016/184882 24.11.2016
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-06-2025

    Midada

    Published in Swissreg on 01.06.2025

  2. 02-06-2024

    Midada

    Published in Swissreg on 02.06.2024

  3. 29-11-2023

    Midada

    Published in Swissreg on 29.11.2023

  4. 01-06-2023

    Midada

    Published in Swissreg on 01.06.2023

  5. 19-01-2023

    Represchentant inscrit

    Representative
    BOVARD AG, Patent- und Markenanwälte, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 19.01.2023

  6. 18-01-2023

    Concedì

    Published in Swissreg on 18.01.2023

Partidas

Possessur

Pieris Pharmaceuticals GmbH

Lise-Meitner-Strasse 30, 85354 Freising-Weihenstephan, DE

Represchentant

Bovard AG

BOVARD AG

Patent- und Markenanwälte Optingenstrasse 16, 3013 Bern

Inventur

ROTHE, Christine

85221 Dachau, DE

HINNER, Marlon

81247 Munich, DE

BEL AIBA, Rachida, Siham

80469 Munich, DE

SCHLOSSER, Corinna

85354 Freising, DE

OLWILL, Shane

85354 Freising, DE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.